Đang chuẩn bị liên kết để tải về tài liệu:
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Tamoxifen has dramatically reduced the recurrence and mortality rate of estrogen receptor positive breast cancer. However, the efficacy of tamoxifen varies between individuals and 40% of patients will have a recurrence despite adjuvant tamoxifen treatment. Factors that predict tamoxifen efficacy would be helpful for optimizing treatment. |